Vanguard Global Advisers’s Veracyte VCYT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.51M Buy
32,897
+2,292
+7% +$110K ﹤0.01% 1451
2026
Q2
$1.8M Sell
30,605
-906
-3% -$38K ﹤0.01% 1330
2026
Q1
$1.01M Buy
+31,511
New +$1.17M ﹤0.01% 1651

Other funds holding VCYT

Vanguard Global Advisers's VCYT Position: Q3 2026 in Review

Vanguard Global Advisers increased its Veracyte (VCYT) stake by 7.5% in Q3 2026, buying an estimated $110K and bringing the position to 32,897 shares worth $1.51M. The position accounts for ﹤0.01% of the portfolio, ranked #1451.

Vanguard Global Advisers first reported a position in VCYT in Q1 2026 and has held it in 3 quarters since. The position peaked at $1.8M in Q2 2026. 383 funds tracked by Wall St. Rank hold VCYT as of Q3 2026.

  • Vanguard Global Advisers held 32,897 shares of Veracyte worth $1.51M as of Q3 2026.
  • Vanguard Global Advisers bought 2,292 Veracyte shares in Q3 2026, an estimated $110K.
  • Veracyte made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #1451 holding.
  • Vanguard Global Advisers first reported a position in Veracyte in Q1 2026 and has held it in 3 quarters since.
  • Vanguard Global Advisers's Veracyte position peaked at $1.8M in Q2 2026.
  • 383 funds tracked by Wall St. Rank held Veracyte as of Q3 2026.

Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.